CISATRACURIUM DEMOGEN (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)
Product name
CISATRACURIUM DEMOGEN
Date registered
Evaluation commenced
Decision date
Approval time
109 (255 working days)
Active ingredients
cisatracurium besilate
Registration type
New generic medicine
Indication
CISATRACURIUM DEMOGEN injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.